Last Posted: Jan 10, 2019
- A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases.
Oliveri Serena et al. Frontiers in genetics 2018 9624 - Benefits of introduction of Oncotype DX ® testing.
Green N et al. Annals of the Royal College of Surgeons of England 2019 Jan 101(1) 55-59 - Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.
Younes Nadin et al. Gene 2019 Feb 684154-164 - Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer.
Wendt Camilla et al. Acta oncologica (Stockholm, Sweden) 2019 Jan 1-12 - TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.
Bakhuizen J J et al. Familial cancer 2019 Jan - Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriers.
Lubinski Jan et al. Breast cancer research and treatment 2019 Jan - Clinical implications of germline mutations in breast cancer genes: RECQL.
Bowden A Ramsay et al. Breast cancer research and treatment 2019 Jan - Clinical target sequencing for precision medicine of breast cancer.
Tsuchida Junko et al. International journal of clinical oncology 2019 Jan - Cost-utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain.
Moya-Alarcón Carlota et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2019 Jan - Global Disparities in Breast Cancer Genetics Testing, Counselling and Management.
Yip C H et al. World journal of surgery 2019 Jan
No hay comentarios:
Publicar un comentario